Latest Insurance News

Neurotech International has initiated an Authorised Prescriber program for its lead therapy NTI164, expanding access for children with neurodevelopmental disorders in Australia. The company also secured a Rare Pediatric Disease Designation from the US FDA for NTI164 in Rett Syndrome, marking a key regulatory milestone.

AUB Group has received a revised $45 per share acquisition proposal from EQT, prompting the board to grant exclusivity for due diligence. The deal remains non-binding and subject to multiple conditions.

Whitefield Industrials reports a $10.5 million net profit for H1 2026, with a strong 17.1% annualised return over three years, maintaining its track record of benchmark outperformance and announcing a 10.5 cent fully franked dividend.

Emyria reports strong revenue growth driven by expanded insurer-funded mental health programs, marking a significant step in national access to evidence-based PTSD and treatment-resistant depression care.

Income Asset Management reports a 34% rise in Q1 FY2026 revenue despite uncovering a $3 million fraud involving a former employee, maintaining positive EBITDA and strong client engagement.

FINEOS Corporation Holdings PLC reports solid Q3 2025 results, highlighting revenue growth, operational efficiencies, and a key North American client migration to its SaaS platform, underpinning positive free cash flow expectations for FY25.

Phoslock Environmental Technologies reported a $952,000 operating cashflow deficit in Q3 2025 amid rising legal and logistics expenses, while sales volumes improved and production is set to resume in early 2026.

Insurance Australia Group (IAG) reported strong FY25 results and upgraded its FY26 guidance, reflecting the completed RACQ acquisition and ongoing strategic growth initiatives.

Insurance Australia Group (IAG) has upgraded its FY26 financial guidance following the acquisition of RACQ’s insurance business, projecting stronger premium growth and higher profits.

Imricor Medical Systems made significant regulatory strides with FDA submissions for its MRI-guided cardiac ablation devices and launched NorthStar commercially in Europe, even as it reported increased cash outflows in Q3 CY25.

Credit Clear Limited has agreed to acquire UK debt collector ARC Europe for A$10.9 million, backed by a $20.75 million institutional placement led by Chair Paul Dwyer. The deal aims to accelerate growth by integrating Credit Clear’s digital platform into ARC’s established UK operations.

Pinnacle Investment Management has secured a strategic foothold in Japan’s private markets by acquiring up to 13% of Advantage Partners, complementing its strong FY25 growth and global expansion ambitions.